We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Patterson Companies (PDCO) Misses on Earnings & Sales in Q2
Read MoreHide Full Article
Headquartered in St. Paul, MN, Patterson Companies Inc. (PDCO - Free Report) is one of the leading distributors of dental and companion-pet veterinarian supplies in the United States and Canada.
Currently, Patterson Companies has a Zacks Rank #4 (Sell) but that could change following its second-quarter fiscal 2018 earnings report which has just released. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.We have highlighted some of the key details from the just-released announcement below:
Earnings: Patterson Companies posted adjusted earnings from continuing operations of 51 cents, which fell from 56 cents in the year-ago quarter. Furthermore, earnings came below the Zacks Consensus Estimate of 54 cents.
Sales: Net sales fell 2.3% from the year-ago quarter to $1.39 billion, which also missed the Zacks Consensus Estimate of $1. 42 billion. However, adjusting for the effects of foreign currency exchange, sales declined 2.8% on a year-over-year basis.
Key Stats:Patterson Animal Health sales rose 1.4% at constant currency (cc) to $823.6 million, driven by solid contribution from Production animal businesses.
Patterson Dental sales fell 8.4% at cc to $553.6 million. The downside came from the decrease in sales of CEREC and digital technology products.
Coming to guidance, the company expects adjusted earnings per share for fiscal 2018 in the range of $2.00 to $2.10 per share, way below the previously issued band of $2.25 to $2.40 per diluted share.
Check back for our full write up on this Patterson Companies earnings report later!
Zacks' Hidden Trades
While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?
Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum...from stocks under $10 to ETF to option movers...from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors.
Image: Bigstock
Patterson Companies (PDCO) Misses on Earnings & Sales in Q2
Headquartered in St. Paul, MN, Patterson Companies Inc. (PDCO - Free Report) is one of the leading distributors of dental and companion-pet veterinarian supplies in the United States and Canada.
Currently, Patterson Companies has a Zacks Rank #4 (Sell) but that could change following its second-quarter fiscal 2018 earnings report which has just released. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.We have highlighted some of the key details from the just-released announcement below:
Earnings: Patterson Companies posted adjusted earnings from continuing operations of 51 cents, which fell from 56 cents in the year-ago quarter. Furthermore, earnings came below the Zacks Consensus Estimate of 54 cents.
Sales: Net sales fell 2.3% from the year-ago quarter to $1.39 billion, which also missed the Zacks Consensus Estimate of $1. 42 billion. However, adjusting for the effects of foreign currency exchange, sales declined 2.8% on a year-over-year basis.
Patterson Companies, Inc. Price and Consensus
Patterson Companies, Inc. Price and Consensus | Patterson Companies, Inc. Quote
Key Stats:Patterson Animal Health sales rose 1.4% at constant currency (cc) to $823.6 million, driven by solid contribution from Production animal businesses.
Patterson Dental sales fell 8.4% at cc to $553.6 million. The downside came from the decrease in sales of CEREC and digital technology products.
Coming to guidance, the company expects adjusted earnings per share for fiscal 2018 in the range of $2.00 to $2.10 per share, way below the previously issued band of $2.25 to $2.40 per diluted share.
Check back for our full write up on this Patterson Companies earnings report later!
Zacks' Hidden Trades
While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?
Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum...from stocks under $10 to ETF to option movers...from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors.
Click here for Zacks' secret trade>>